Literature DB >> 11299822

Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.

R Ohashi1, C Gao, M Miyazaki, K Hamazaki, T Tsuji, Y Inoue, T Uemura, R Hirai, N Shimizu, M Namba.   

Abstract

BACKGROUND: Disruption of the G1/S check point leads to uncontrolled cell growth, resulting in the development of cancers.
MATERIALS AND METHODS: Cell cycle regulatory molecules were investigated in 33 surgically resected hepatocellular carcinoma (HCC) samples from 30 patients by Western blotting.
RESULTS: Enhanced expressions of cyclin E and cyclin A were detected at frequencies of 18/33 and 26/33 in HCCs, respectively, as compared with their neighboring noncancerous tissues. The enhanced expression of cyclin E, but not that of cyclin A, correlated with hyperphosphorylation of pRb and high frequency of Ki-67-positive cells. Thus, the HCCs with enhanced cyclin E expression probably contain a relatively large number of proliferating cancer cells.
CONCLUSIONS: The degree of cyclin E expression can be used as a prognostic parameter of HCC. In addition, cyclin E may become a molecular target in the treatment of HCCs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299822

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  18 in total

1.  TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.

Authors:  Ji Yeon Baek; Shelli M Morris; Jean Campbell; Nelson Fausto; Matthew M Yeh; William M Grady
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

2.  Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer Prevention.

Authors:  Rakesh Dachineni; Guoqiang Ai; D Ramesh Kumar; Satya S Sadhu; Hemachand Tummala; G Jayarama Bhat
Journal:  Mol Cancer Res       Date:  2015-12-18       Impact factor: 5.852

Review 3.  The prognostic molecular markers in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.

Authors:  Khaled Aziz; Jazeel F Limzerwala; Ines Sturmlechner; Erin Hurley; Cheng Zhang; Karthik B Jeganathan; Grace Nelson; Steve Bronk; Raul O Fierro Velasco; Erik-Jan van Deursen; Daniel R O'Brien; Jean-Pierre A Kocher; Sameh A Youssef; Janine H van Ree; Alain de Bruin; Hilda van den Bos; Diana C J Spierings; Floris Foijer; Bart van de Sluis; Lewis R Roberts; Gregory J Gores; Hu Li; Jan M van Deursen
Journal:  Gastroenterology       Date:  2019-03-13       Impact factor: 22.682

5.  Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori-induced gastric precancerosis.

Authors:  Yong-Li Yao; Bo Xu; Yu-Gang Song; Wan-Dai Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

Review 6.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

7.  Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.

Authors:  Qi Zhou; Qiang He; Li-Jian Liang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

Review 8.  Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy.

Authors:  Maayan Salton; Tom Misteli
Journal:  Trends Mol Med       Date:  2015-12-14       Impact factor: 11.951

9.  Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma.

Authors:  K T Ng; K Man; C K Sun; T K Lee; R T Poon; C-M Lo; S-T Fan
Journal:  Br J Cancer       Date:  2006-09-26       Impact factor: 7.640

10.  SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice.

Authors:  Salvatore Delogu; Chunmei Wang; Antonio Cigliano; Kirsten Utpatel; Marcella Sini; Thomas Longerich; Nina Waldburger; Kai Breuhahn; Lijie Jiang; Silvia Ribback; Frank Dombrowski; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Oncotarget       Date:  2015-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.